DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Peng Li, Yuanbin Cui et al.|Molecular Therapy — Oncolytics|2022Cited by 19
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell MalignanciesDiwei Zheng, Peng Li, Xindong Wang et al.|Frontiers in Immunology|2022Cited by 14